EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Prognostic Significance of Secondary‐Type Mutations in NPM1 ‐Mutated Acute Myeloid Leukemia

Kun Yang iD, Hongmei Luo, Bing Xiang iD, Yang Dai, Yuping Gong iD, Jie Huang, Jianjun Li iD, Yongqian Jia, Yong Guo, Yuhuan Zheng, Hongbing Ma

Cancer Medicine · 2026

DOI: 10.1002/cam4.72278 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cancer Medicine, 2026. Verfasst von Kun Yang und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Hematology, West China Hospital, Sichuan University, Chengdu, China. Hauptthemen laut MEDLINE: Leukemia, Myeloid, Acute, Mutation, Nuclear Proteins. Die Arbeit nennt 26 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: General Program of the Natural Science Foundation of Sichuan Provincial Department of Science and Technology.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

NPM1 is among the most frequently mutated genes in acute myeloid leukemia (AML), and NPM1 ‐mutated AML is generally associated with a favorable prognosis. However, substantial prognostic heterogeneity exists within this population. The prognostic significance of secondary‐type mutations (STMs) in NPM1 ‐mutated AML remains controversial. In this retrospective study of 179 patients with NPM1 ‐mutated AML, the prognostic effects of age, common comutations, and STMs were evaluated. Multivariate analysis revealed that age ≥ 60 years and the presence of FLT3‐ITD mutations were independently associated with poor overall survival (OS). Patients with NPM1/FLT3‐ITD/DNMT3A triple mutations had the shortest median OS among the molecular subgroups examined. The treatment response did not differ significantly between STM‐positive and STM‐negative patients. No statistically significant association between STM status and OS was observed in the overall cohort or in exploratory subgroup analyses stratified by ELN 2022 risk category and age. Sensitivity analyses accounting for stem cell transplantation and untreated patients yielded similar results. Given the limited number of STM‐positive patients, larger studies are needed to further clarify the prognostic significance of STMs in NPM1 ‐mutated AML.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Leukemia, Myeloid, AcuteMutationNuclear ProteinsHumansNucleophosminPrognosisFemaleMiddle Agedfms-Like Tyrosine Kinase 3AgedMaleAdultRetrospective StudiesAged, 80 and overYoung AdultDNA Methyltransferase 3ADNA (Cytosine-5-)-Methyltransferases

Stichwörter der Autor:innen

NPM1 mutationacute myeloid leukemiarisk stratificationsecondary‐type mutation

Substanzen

NucleophosminNPM1 protein, humanNuclear Proteinsfms-Like Tyrosine Kinase 3FLT3 protein, humanDNA Methyltransferase 3ADNA (Cytosine-5-)-MethyltransferasesDNMT3A protein, human

Autor:innen und Institutionen

  • Department of Hematology, West China Hospital, Sichuan University, Chengdu, China.

ORCID-Profile: Kun Yang, Bing Xiang, Yuping Gong, Jianjun Li

Förderung

  • General Program of the Natural Science Foundation of Sichuan Provincial Department of Science and Technology

Zitieren

APA

Yang, K., Luo, H., Xiang, B., Dai, Y., Gong, Y., Huang, J., Li, J., Jia, Y., Guo, Y., Zheng, Y., & Ma, H. (2026). Prognostic Significance of Secondary‐Type Mutations in NPM1 ‐Mutated Acute Myeloid Leukemia. Cancer Medicine. https://doi.org/10.1002/cam4.72278

Vancouver

Yang K, Luo H, Xiang B, Dai Y, Gong Y, Huang J, et al. Prognostic Significance of Secondary‐Type Mutations in NPM1 ‐Mutated Acute Myeloid Leukemia. Cancer Medicine. 2026. doi:10.1002/cam4.72278

BibTeX
@article{Yang2026,
  author = {Yang, Kun and Luo, Hongmei and Xiang, Bing and Dai, Yang and Gong, Yuping and Huang, Jie and Li, Jianjun and Jia, Yongqian and Guo, Yong and Zheng, Yuhuan and Ma, Hongbing},
  title = {Prognostic Significance of Secondary‐Type Mutations in NPM1 ‐Mutated Acute Myeloid Leukemia},
  journal = {Cancer Medicine},
  year = {2026},
  doi = {10.1002/cam4.72278}
}
Kostenlos starten →